Investor Rights Agreements in the Health Care Equipment & Supplies Industry
123 Contracts & Agreements
- ACCURAY INC (1 contract)
- Acrivon Therapeutics, Inc. (1)
- Acutus Medical, Inc. (1)
- ADNEXUS THERAPEUTICS, INC. (1)
- Affinia Therapeutics Inc. (1)
- ANTARES PHARMA, INC. (2)
- Apollo Endosurgery, Inc. (1)
- ARATANA THERAPEUTICS, INC. (3)
- AtriCure, Inc. (1)
- Audentes Therapeutics, Inc. (1)
- Avinger Inc (1)
- Axonics Modulation Technologies, Inc. (2)
- Cadrenal Therapeutics, Inc. (1)
- Cardiovascular Systems Inc (4)
- CARGO Therapeutics, Inc. (2)
- CESCA THERAPEUTICS INC. (1)
- Cirius Therapeutics, Inc. (1)
- Civitas Therapeutics, Inc. (1)
- CORNERSTONE THERAPEUTICS INC (1)
- Coya Therapeutics, Inc. (1)
- Cue Health Inc. (1)
- CVRx, Inc. (1)
- DarioHealth Corp. (1)
- Dimension Therapeutics, Inc. (1)
- Durata Therapeutics, Inc. (1)
- Eargo, Inc. (2)
- electroCore, Inc. (2)
- Elicio Therapeutics, Inc. (1)
- ESTABLISHMENT LABS HOLDINGS INC. (1)
- FEMASYS INC (2)
- GI DYNAMICS, INC. (1)
- GLAUKOS Corp (3)
- Globus Medical Inc. (2)
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (1)
- HYPERION THERAPEUTICS INC (1)
- Inari Medical, Inc. (1)
- Inogen, Inc. (3)
- INTARCIA THERAPEUTICS, INC (1)
- Invea Therapeutics, Inc (1)
- IRADIMED CORP (1)
- iRhythm Technologies, Inc. (2)
- IRIDEX CORP (2)
- Juno Therapeutics, Inc. (5)
- Lexeo Therapeutics, Inc. (1)
- Lucira Health, Inc. (1)
- Mineralys Therapeutics, Inc. (1)
- Neumora Therapeutics, Inc. (1)
- Neuronetics, Inc. (1)
- NeuroPace Inc (1)
- OBALON THERAPEUTICS INC (1)
- OSIRIS THERAPEUTICS, INC. (2)
- Pandion Therapeutics Holdco LLC (1)
- Paragon 28, Inc. (1)
- Peloton Therapeutics, Inc. (1)
- Penumbra Inc (1)
- Precision Therapeutics Inc. (1)
- PROCEPT BioRobotics Corp (1)
- Pulmonx Corp (2)
- ReShape Lifesciences Inc. (1)
- Restoration Robotics, Inc. (2)
- RTI Surgical Holdings, Inc. (1)
- RTI SURGICAL, INC. (1)
- RxSight, Inc. (1)
- Sandbridge Acquisition Corp (1)
- Semler Scientific, Inc. (1)
- Senseonics Holdings, Inc. (2)
- ShockWave Medical, Inc. (1)
- SI-BONE, Inc. (2)
- Sientra, Inc. (1)
- Sight Sciences, Inc. (2)
- Sonendo, Inc. (1)
- Spark Therapeutics, Inc. (1)
- Stereotaxis, Inc. (1)
- Structure Therapeutics Inc. (1)
- Talis Biomedical Corp (1)
- TANDEM DIABETES CARE INC (1)
- TearLab Corp (3)
- TELA Bio, Inc. (2)
- Tobira Therapeutics, Inc. (2)
- TransMedics Group, Inc. (2)
- Trius Therapeutics Inc (1)
- ViewRay, Inc. (3)
- Vividion Therapeutics, Inc. (1)
- VYCOR MEDICAL INC (1)
- Xtant Medical Holdings, Inc. (2)
- Amended and Restated Investors Rights Agreement, dated November 9, 2021 (Kyverna Therapeutics, Inc., Filed With SEC on January 16, 2024)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated May 24, 2023 (Carmot Therapeutics Inc., Filed With SEC on November 17, 2023)
- Amended and Restated Investors Rights Agreement, dated, February 9, 2023, by and among the Registrant and the investors listed therein (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Amended and Restated Investors Rights Agreement, dated, February 9, 2023, by and among the Registrant and the investors listed therein (CARGO Therapeutics, Inc., Filed With SEC on October 20, 2023)
- AMENDEDAND RESTATED INVESTORS RIGHTS AGREEMENT (Invea Therapeutics, Inc, Filed With SEC on October 20, 2023)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated August 10, 2021 (Lexeo Therapeutics, Inc., Filed With SEC on September 29, 2023)
- Investors Rights Agreement, dated September 22, 2022, by and among the Registrant and the investors listed therein (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
- Amendment No. 1 to Investor Rights Agreement dated as of May 2, 2023 among Xtant Medical Holdings, Inc., OrbiMed Royalty Opportunities II, LP and ROS Acquisition Offshore LP (Xtant Medical Holdings, Inc., Filed With SEC on May 4, 2023)
- Investment Agreement, dated February 17, 2023, by and among Owlet, Inc. and the investors listed on Schedule I thereto (Excluded Investors) (Sandbridge Acquisition Corp, Filed With SEC on February 21, 2023)
- Amended and Restated Investors Rights Agreement, dated June 1, 2022, by and among the Registrant and certain of its stockholders (Mineralys Therapeutics, Inc., Filed With SEC on January 18, 2023)
- Amended and Restated Investors Rights Agreement, dated July 30, 2021, by and between the registrant and the investors named therein (Structure Therapeutics Inc., Filed With SEC on January 12, 2023)
- First Amended Investors Rights Agreement dated as of March 4, 2022, by and among Coya Therapeutics, Inc. and certain holders of its capital stock(c)(d) (Coya Therapeutics, Inc., Filed With SEC on November 18, 2022)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 9, 2021 (Acrivon Therapeutics, Inc., Filed With SEC on October 17, 2022)
- Investors Rights Agreement, dated as of October 4, 2022, by and among the Company, The Ma-Ran Foundation, The Gary W. Rollins Foundation and Jason Isenberg, as the RFA Sellers... (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on October 11, 2022)
- Form of Investor Rights and Lockup Agreement (Cadrenal Therapeutics, Inc., Filed With SEC on September 22, 2022)
- Investors Rights Agreement, dated June 24, 2022, by and between Eargo, Inc. and those certain investors set forth therein (Eargo, Inc., Filed With SEC on June 27, 2022)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated April 20, 2021 (Affinia Therapeutics Inc., Filed With SEC on January 4, 2022)
- Investor Rights Agreement, dated December 15, 2021, by and between Venus Concept Inc. and certain investors listed therein (Restoration Robotics, Inc., Filed With SEC on December 15, 2021)
- Third Amended and Restated Investors Rights Agreement by and among Sonendo, Inc. and the investors listed therein (Sonendo, Inc., Filed With SEC on October 8, 2021)
- Amended and Restated Investors Rights Agreement, by and between Paragon 28, Inc. and the investors party thereto, dated as of July 28, 2020 (Paragon 28, Inc., Filed With SEC on September 24, 2021)
- Amended and Restated Investors Rights Agreement, dated June 1, 2020 by and among the Registrant and the investors party thereto (Cue Health Inc., Filed With SEC on September 1, 2021)
- Amended and Restated Investor Rights Agreement, by and among the Registrant and the investors named therein and the founder named therein, dated June 10, 2021 (PROCEPT BioRobotics Corp, Filed With SEC on August 18, 2021)
- Amended and Restated Investor Rights Agreement among the Registrant and certain of its stockholders, dated February 24, 2017 (RxSight, Inc., Filed With SEC on July 9, 2021)
- Third Amended and Restated Investors Rights Agreement, dated as of November 23, 2020, as amended (Sight Sciences, Inc., Filed With SEC on July 8, 2021)
- Form of Amended and Restated Investors Rights Agreement, dated August 30, 2018, by and among the Registrant and certain of its stockholders, as amended by that certain Omnibus... (Elicio Therapeutics, Inc., Filed With SEC on June 28, 2021)
- Third Amended and Restated Investors Rights Agreement, dated February 18, 2021, by and among the Registrant and certain of its stockholders (Vividion Therapeutics, Inc., Filed With SEC on June 25, 2021)
- Third Amended and Restated Investors Rights Agreement, dated as of November 23, 2020 (Sight Sciences, Inc., Filed With SEC on June 23, 2021)
- Eighth Amended and Restated Investors Rights Agreement, dated July 1, 2020, by and among the Company and the holders listed therein (CVRx, Inc., Filed With SEC on June 4, 2021)
- Amendment No. 1 to Third Amended and Restated Investor Rights Agreement, dated April 2, 2021, among Femasys Inc. and the Investors party thereto (FEMASYS INC, Filed With SEC on May 14, 2021)
- Third Amended and Restated Investor Rights Agreement, dated January 6, 2017, among Femasys Inc. and the Investors party thereto (FEMASYS INC, Filed With SEC on May 14, 2021)
- Amended and Restated Investors Rights Agreement, dated August 19, 2020, by and among the Registrant and the investors listed on Exhibit A thereto (NeuroPace Inc, Filed With SEC on March 24, 2021)
- Amended and Restated Investor Rights Agreement, dated October 30, 2020, by and among the Registrant and certain of its stockholders (Talis Biomedical Corp, Filed With SEC on January 22, 2021)
- Amended and Restated Investor Rights Agreement, dated August 7, 2020, by and among the registrant and the investors listed on Schedule A thereto (Lucira Health, Inc., Filed With SEC on January 15, 2021)
- Amended and Restated Investors Rights Agreement, dated July 13, 2020, by and among Eargo, Inc. and the investors listed therein (Eargo, Inc., Filed With SEC on September 25, 2020)
- Investor Rights Agreement (GI DYNAMICS, INC., Filed With SEC on September 10, 2020)
- Amended and Restated Investors Rights Agreement by and among Pulmonx Corporation and certain of its stockholders, dated April 16, 2019 (Pulmonx Corp, Filed With SEC on September 4, 2020)
- Investor Rights Agreement, dated as of August 9, 2020, by and between the Registrant and certain purchasers named therein (Senseonics Holdings, Inc., Filed With SEC on August 31, 2020)
- Investor Rights Agreement, dated as of August 9, by and between the Registrant and PHC Holding Corporation (Senseonics Holdings, Inc., Filed With SEC on August 31, 2020)
- Amended and Restated Investors Rights Agreement, dated June 12, 2019, among the Registrant and certain of its stockholders (Acutus Medical, Inc., Filed With SEC on July 15, 2020)
- Amended and Restated Investors Rights Agreement, dated as of March 23, 2020, by and among the Registrant and the other parties thereto (Pandion Therapeutics Holdco LLC, Filed With SEC on June 26, 2020)